BCRX Insider Trading Activity and SEC Form 4 Filings
BCRX insider trading summary
Over the past 12 months, insiders at Biocryst Pharmaceuticals Inc (BCRX) reported 10 sales worth $4.1M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $4.1M.
Latest BCRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 18, 2026 | Amy E McKee | Director | Sell | $100K (11,180 @ $8.97) |
| May 13, 2026 | Alane P Barnes | Chief Legal Officer | Sell | $596K (62,500 @ $9.54) |
| Mar 20, 2026 | Theresa Heggie | Director | Sell | $505K (49,933 @ $10.11) |
| Mar 16, 2026 | Alane P Barnes | Chief Legal Officer | Sell | $1.4M (150,000 @ $9.15) |
| Dec 22, 2025 | Alane P Barnes | Chief Legal Officer | Sell | $167K (21,773 @ $7.65) |
| Dec 15, 2025 | Alane P Barnes | Chief Legal Officer | Sell | $162K (21,210 @ $7.65) |
| Dec 3, 2025 | Alane P Barnes | Chief Legal Officer | Sell | $151K (19,770 @ $7.65) |
| Dec 2, 2025 | Alane P Barnes | Chief Legal Officer | Sell | $367K (50,906 @ $7.21) |
| Dec 1, 2025 | Alane P Barnes | Chief Legal Officer | Sell | $647K (91,004 @ $7.10) |
| Nov 13, 2025 | Machelle Sanders | Director | Sell | $69K (9,600 @ $7.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.